Expression of nm23/nucleoside diphosphate kinase-a protein in endometrial carcinoma

Gynecologic Oncology

Volumn 66, Issue 2, 1997, Pages 238-245

  Srivatsa, Preeti J ^a   Cliby, William A ^a   Keeney, Gary L ^a   Suman, Vera J ^a   Harmsen, William S ^a   Ziesmer, Steven C ^a   Roche, Patrick C ^a   Podratz, Karl C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; MYOMETRIUM; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

EID: 0031214149     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4744     Document Type: Article

References (27)

1. Steeg P S, Bevilacqua G, Kopper L, Thorgeirsson U P, Talmadge J E, Liotta L A, Sobel M E. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 80:1988;200-204.
2. Stahl J A, Leone A, Rosengard A M, Porter L, King C R, Steeg P S. Identification of a second human nm23 gene, nm23-H2. Cancer Res. 51:1991;445-449.
3. Bominaar A A, Molijn A C, Pestel M, Veron M, Van Haastert P J. Activation of G-proteins by receptor-stimulated nucleoside diphosphate kinase in Dictyostelium. EMBO J. 12:1993;2275-2279.
4. Royds J A, Rees R C, Stephenson T J. nm23 - A metastasis suppressor gene? J Pathol. 173:1994;211-212.
5. Wallet V, Mutzel R, Troll H, Barzu O, Wurster B, Veron M, Lacombe M L. Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development. J Natl Cancer Inst. 82:1990;1199-1202.
6. Steeg P S, de la Rosa A, Flatow U, MacDonald N J, Benedict M, Leone A. Nm23 and breast cancer metastasis. Breast Cancer Res Treat. 25:1993;175-187.
7. Leone A, Seeger R C, Hong C M, Hu Y Y, Arboleda M J, Brodeur G M, Stram D, Slamon D J, Steeg P S. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene. 8:1993;855-865.
8. Myeroff L L, Markowitz S D. Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst. 85:1993;147-152.
9. Steeg P S, Cohn K H, Leone A. Tumor metastasis and nm23: Current concepts. Cancer Cells. 3:1991;257-262.
10. Malkasian G D Jr, McDonald T W, Pratt J H. Carcinoma of the endometrium: Mayo Clinic experience. Mayo Clin Proc. 52:1977;175-180.
11. DiSaia P J, Creasman W T, Boronow R C, Blessing J A. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol. 151:1985;1009-1015.
12. Grigsby P W, Perez C A, Kuske R R, Kao M S, Galakatos A E. Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium. Gynecol Oncol. 27:1987;44-57.
13. Creasman W T, Morrow C P, Bundy B N, Homesley H D, Graham J E, Heller P B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 60:1987;2035-2041.
14. Harouny V R, Sutton G P, Clark S A, Geisler H E, Stehman F B, Ehrlich C E. The importance of peritoneal cytology in endometrial carcinoma. Obstet Gynecol. 72:1988;394-398.
15. Ehrlich C E, Young P C, Stehman F B, Sutton G P, Alford W M. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol. 158:1988;796-807.
16. Rosenberg P, Wingren S, Simonsen E, Stal O, Risberg B, Nordenskjold B. Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: An important prognostic indicator. Gynecol Oncol. 35:1989;50-54.
17. Britton L C, Wilson T O, Gaffey T A, Cha S S, Wieand H S, Podratz K C. DNA ploidy in endometrial carcinoma: Major objective prognostic factor. Mayo Clin Proc. 65:1990;643-650.
18. Hetzel D J, Wilson T O, Keeney G L, Roche P C, Cha S S, Podratz K C. HER-2/neu expression: A major prognostic factor in endometrial cancer. Gynecol Oncol. 47:1992;179-185.
19. Kohler M F, Berchuck A, Davidoff A M, Humphrey P A, Dodge R K, Iglehart J D, Soper J T, Clarke-Pearson D L, Bast R C Jr, Marks J R. Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res. 52:1992;1622-1627.
20. Royds J A, Stephenson T J, Rees R C, Shorthouse A J, Silcocks P B. Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst. 85:1993;727-731.
21. Lacombe M L, Sastre-Garau X, Lascu I, Vonica A, Wallet V, Thiery J P, Veron M. Overexpression of nucleoside diphosphate kinase (nm23) in solid tumours. Eur J Cancer. 27:1991;1302-1307.
22. MacDonald N J, De la Rosa A, Benedict M A, Freije J M, Krutsch H, Steeg P S. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem. 268:1993;25,780-25,789.
23. Agarwal R P, Robinson B, Parks R E Jr. Nucleoside diphosphokinase form human erythrocytes. Methods Enzymol. 51:1978;376-386.
24. Teng D H, Engele C M, Venkatesh T R. A product of the prune locus of Drosophila is similar to mamalian GTPase-activating protein. Nature. 353:1991;437-440.
25. Wakefield L M, Thompson N L, Flanders K C, O'Connor-McCourt M D, Sporn M B. Transforming growth factor-beta: Multifunctional regulator of cell growth and phenotype. Ann NY Acad Sci. 551:1988;290-297.
26. Srivatsa P J, Cliby W A, Keeney G L, Dodson M K, Suman V J, Roche P C, Podratz K C. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. Gynecol Oncol. 60:1996;363-372.
27. Watanabe J, Sato Y, Kuramoto H, Kameya T. Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma. Br J Cancer. 72:1995;1469-1473.